Effect of Lactiplantibacillus Plantarum DAD-13 on Inflammatory Markers in ICU Sepsis Patients

NCT07072871 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis
Systemic Inflammatory Response Syndrome (SIRS)
Critical Illness

Interventions

DIETARY_SUPPLEMENT: Lactiplantibacillus plantarum DAD-13
DRUG: Placebo

Sponsor

PT Royal Medikalink Pharmalab